Metabolic syndrome criteria as predictors of insulin resistance, inflammation and mortality in Chronic Hemodialysis Patients

Metabolic Syndrome and Related Disorders

Volumn 12, Issue 8, 2014, Pages 443-449

  Vogt, Barbara Perez ^a   Souza, Priscilla L ^a   Minicucci, Marcos Ferreira ^a   Martin, Luis Cuadrado ^a   Barretti, Pasqual ^a   Caramori, Jacqueline Teixeira ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; TRIACYLGLYCEROL; UREA;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BODY HEIGHT; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; OBSERVATIONAL STUDY; SURVIVAL PREDICTION; SURVIVAL TIME; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; WAIST CIRCUMFERENCE; CHRONIC KIDNEY FAILURE; COMPLICATION; FOLLOW UP; METABOLISM; MIDDLE AGED; RENAL REPLACEMENT THERAPY; RISK; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK; YOUNG ADULT;

EID: 84907285172     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2014.0011     Document Type: Article

References (26)

1. Calabrò P, Golia E, Maddaloni V, et al. Adipose tissuemediated inflammation: The missing link between obesity and cardiovascular disease? Intern Emerg Med 2009;4:25-34.
2. Grundy SM,Cleeman JI,Daniels SR,et al., Diagnosis and management of the metabolic syndrome, An American Heart Association/National Heart Lung, and Blood Institute Scientific Statement, Executive summary. Cardiol Rev, 2005, 13, 322-327.
3. Laaksonen DE, Lakka H-M, Niskanen LK, et al. Metabolic syndrome and development of diabetes mellitus: Application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002;156:1070-1077.
4. Lakka H-M, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-2716.
5. Schiffrin EL, Lipman ML, Mann JFE. Chronic kidney disease: Effects on the cardiovascular system. Circulation 2007;116:85-97.
6. Park S-H, Lindholm B. Definition of metabolic syndrome in peritoneal dialysis. Perit Dial Int 2009;29(Suppl 2): S137-S144.
7. Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Int ernational Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-1645.
8. Guarnieri G, Zanetti M, Vinci P, et al. Insulin resistance in chronic uremia. J Ren Nutr 2009;19:20-24.
9. Shinohara K, Shoji T, Emoto M, et al. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal di sease. J Am Soc Nephrol 2002;13:1894-1900.
10. Fouque D, Kalantar-Zadeh K, Kopple J, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008;73:391-398.
11. Shoji T, Nishizawa Y. Chronic kidney disease as a metabolic syndrome with malnutrition-need for strict control of risk factors. Intern Med 2005;44:179-187.
12. Kalantar-Zadeh K, Block G, Humphreys MH, et al. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003;63:793-808.
13. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
14. Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: An analysis of error. J Am Soc Nephrol 1993;4:1205-1213.
15. Grundy SM, Hansen B, Smith SC Jr, et al. Clinical management of metabolic syndrome: Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Arterioscler Thromb Vasc Biol 2004;24:e19-e24.
16. Alberti KGMM, Zimmet P, Shaw J. The metabolic syndrome-A new worldwide definition. Lancet 2005;366: 1059-1062.
17. Ucar E, Huzmeli C, Guven O, et al. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions. Ren Fail 2009;31:221-228.
18. Maheshwari N, Ansari MR, Darshana METSL, et al. Pattern of lipid profile in patients on maintenance hemodialysis. Saudi J Kidney Dis Transplant 2010;21:565-570.
19. Arslan Y, Kiziltan G. Nutrition-related cardiovascular risk factors in hemodialysis patients. J Ren Nutr 2010;20:185-192.
20. Carrero JJ, Stenvinkel P. Inflamm ation in end-stage renal disease-what have we learned in 10 years? Semin Dial 2010;23:498-509.
21. Siew ED, Ikizler TA. Insulin resistance and protein energy metabolism in patients with advanced chronic kidney disease. Semin Dial 2010;23:378-382.
22. Young DO, Lund RJ, Haynatzki G, et al. Prevalence of the metabolic syndrome in an incident dialysis population. Hemodial Int 2007;11:86-95.
23. Jalalzadeh M,Mohammadi R,Mirzamohammadi F,et al., Prevalence of metabolic syndrome in a hemodialysis population, Iran J Kidney Dis, 2011, 5, 248-254.
24. Johnson DW, Armstrong K, Campbell SB, et al. Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification. Nephrology (Carlton) 2007;12:391-398.
25. Stolic RV, Trajkovic GZ, Peric VM, et al. Impact of metabolic syndrome and malnutrition on mortality in chronic hemodialysis patients. J Ren Nutr 2010;20:38-43.
26. Park JT, Chang TI, Kim DK, et al. Metabolic syndrome predicts mortality in non-diabetic patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2010;25:599-604.